Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Celine Auzanneau"'
Autor:
Carine Bellera, Jean-Philippe Metges, Carlos Gomez-Roca, Simon Pernot, François Le Loarer, Celine Auzanneau, Jean-Philippe Guegan, Isabelle Soubeyran, Sophie Cousin, Alban Bessede, Antoine Adenis, Antoine Italiano, Coralie Cantarel, Michèle Kind
Publikováno v:
Clinical Cancer Research. 27:2139-2147
Purpose: Regorafenib is synergistic with immune checkpoint inhibition in colorectal cancer preclinical models. Patients and Methods: This was a single-arm, multicentric phase II trial. Regorafenib was given 3 weeks on/1 week off, 160 mg every day; av
Autor:
Antoine Italiano, Nicolas Isambert, Jean-Philippe Metges, Maud Toulmonde, Sophie Cousin, Simon Pernot, Mariella Spalato, Thomas Grellety, Celine Auzanneau, Barbara Lortal, Michèle Kind, François Le Loarer, Sabrina Sellan-Albert, Carine A. Bellera
Publikováno v:
Journal of Clinical Oncology. 40:TPS2703-TPS2703
TPS2703 Background: Recent studies have shown shown that genetic depletion of EZH2 in Tregs (using FoxP3creEZH2fl/fl mice) and pharmacological inhibition of EZH2 elicits phenotypic and functional alterations of Tregs, leading to an effector-like T ce
Autor:
Amandine Crombé, Sophie Cousin, Yec'han Laizet, Carlo Lucchesi, Celine Auzanneau, Antoine Italiano, Sylvestre Le Moulec, Maud Toulmonde, Isabelle Soubeyran, Emmanuel Khalifa
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-3 (2018)
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-3 (2018)
Preclinical data have shown that ERBB2 activating mutations are responsive to HER2 tyrosine kinase inhibitors. The aim of this study is to characterize the landscape of ERBB2 mutations in solid tumors and the potential efficacy of ERBB2 targeting. We
Autor:
Antoine Italiano, Derek Dinart, Isabelle Soubeyran, Carine Bellera, Hélène Espérou, Christelle Delmas, Noémie Mercier, Sabrina Albert, Ludivine Poignie, Anne Boland, Aurélien Bourdon, Damien Geneste, Quentin Cavaille, Yec’han Laizet, Emmanuel Khalifa, Céline Auzanneau, Barbara Squiban, Nathalène Truffaux, Robert Olaso, Zuzana Gerber, Cédrick Wallet, Antoine Bénard, Jean-Yves Blay, Pierre Laurent-Puig, Jean-François Deleuze, Carlo Lucchesi, Simone Mathoulin-Pelissier, the MULTISARC study group
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Soft-tissue sarcomas (STS) represent a heterogeneous group of rare tumors including more than 70 different histological subtypes. High throughput molecular analysis (next generation sequencing exome [NGS]) is a unique opportunity
Externí odkaz:
https://doaj.org/article/a537e8b223744e2f9d8f9b6743f5ae55
Autor:
Simone Mathoulin-Pélissier, Antoine Italiano, Anne Boland, Jean-François Deleuze, Helene Blons, Pierre Laurent-Puig, Carine Bellera, Céline Auzanneau, Delphine Bacq, Marlène Boucheix, Aurélien Bourdon, Emmanuelle Chollet, Christine Chomienne, Christelle Delmas, Derek Dinart, Hélène Espérou, Flore Geillon, Damien Geneste, Delphine Jean, Emmanuel Khalifa, Yec'han Laizet, Franck Lethimonnier, Claire Lévy-Marchal, Carlo Lucchesi, Carine Malle, Pierre Mancini, Vincent Meyer, Palomares Marie-Ange, Géraldine Perkins, Sabrina Sellan-Albert, Isabelle Soubeyran, Cédric Wallet
Publikováno v:
ESMO Open, Vol 5, Iss 4 (2020)
Background Whole exome sequencing and RNA sequencing (WES/RNASeq) should now be implemented in the clinical practice in order to increase access to optimal care for cancer patients. Providing results to Tumour Boards in a relevant time frame—that i
Externí odkaz:
https://doaj.org/article/a478a16ea5ed4bfc9882ed3441d03fae
Autor:
Sophie Cousin, Emmanuel Khalifa, Amandine Crombe, Yech’an Laizet, Carlo Lucchesi, Maud Toulmonde, Sylvestre Le Moulec, Céline Auzanneau, Isabelle Soubeyran, Antoine Italiano
Publikováno v:
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-3 (2018)
Abstract Preclinical data have shown that ERBB2 activating mutations are responsive to HER2 tyrosine kinase inhibitors. The aim of this study is to characterize the landscape of ERBB2 mutations in solid tumors and the potential efficacy of ERBB2 targ
Externí odkaz:
https://doaj.org/article/e90377a4ce3e44979c154ba49dd1440d
Autor:
Sophie Cousin, Thomas Grellety, Maud Toulmonde, Céline Auzanneau, Emmanuel Khalifa, Yec’han Laizet, Kevin Tran, Sylvestre Le Moulec, Anne Floquet, Delphine Garbay, Jacques Robert, Isabelle Hostein, Isabelle Soubeyran, Antoine Italiano
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-3 (2017)
Abstract Previous precision medicine studies have investigated conventional molecular techniques and/or limited sets of gene alterations. The aim of this study was to describe the impact of the next-generation sequencing of the largest panel of genes
Externí odkaz:
https://doaj.org/article/30b626a184794d59ac5cd63e77f5fa69